Membership benefits

Early Access

to latest news and research articles
Members have free and unrestricted access to papers immediately after publication

Members' Services

CES offers free or discounted access to several platforms
Journal subscriptions, publication fees, annual meetings, reagents from industry partners, job postings & more


Eligibility for the Cancer Epigenetics Society Awards
Members can exclusively nominate and be recipients of the Epi Awards

Members' Resources

CES offers several resources to scientists & patients
Several cancer epigenetics databases, meetings, grant & job listings, and continuously expanding resources for scientists & patients

Our databases & journals

Our latest video

The latest news from CES databases & journals

May 1, 2017 - The Cancer Epigenetics Society members major recent contributions to the fields of cancer and epigenetics. may now be followed here!
April 21, 2017- The Cancer Epigenetics Society celebrates its 1st anniversary and the many milestones achieved, including being the largest epigenetics society worldwide!
03/13/2017- Dr. Peter Jones, Chief Scientific Officer of Van Andel Research Institute (VARI, Grand Rapids, MI, USA) is Editor-in-Chief at Cancer Epigenetics
03/09/2017- Dr. Jerry Workman, Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA) is Editor at Cancer Epigenetics
02/21/2017- Dr. Sharon Dent, Director of the Center for Cancer Epigenetics at University of Texas MD Anderson Cancer Center (Houston, TX, USA) is Editor-in-Chief at Cancer Epigenetics


  • No Events

Latest Scientific Cancer Epigenetics News

Latest Medical Cancer Epigenetics News

FDA approves first colorectal cancer screening blood test: the first blood test to detect colorectal cancer approved by the US Food and Drug Administration (FDA) is a cancer epigenetics diagnostic test developed by Epigenomics AG, a German medical diagnostics company that specializes in colorectal and lung cancers. The test detects DNA methylation of Septin 9 (SEPT9), a gene on chromosome 17 whose product controls cytokinesis and cell cycle, which may serve as a tumor suppressor in ovarian cancer, and which is associated to colorectal cancer. The cancer epigenetics diagnostic test offers a minimally invasive alternative to patients who may not be comfortable undergoing a colonoscopy. The diagnostic kit dubbed Epi proColon® was already approved for use in Argentina, China, Europe, and Hong Kong (Cancer Epigenetics Society; medical news).

The Cancer Epigenetics Society in numbers

Society Members:

Continents covered
Affiliate Members
Biomedical MD/PhD Students
Biomedical MD/PhDs

Latest Cancer Epigenetics Society members

Ercan Cacan (Assistant Professor), Department of Molecular Biology and Genetics, Gaziosmanpasa University, Tokat, Turkey
Simone Badal (Lecturer), Department of Basic Medical Sciences, University of the West Indies, Mona, Jamaica
Raja Singh (Director), Alberta Epigenetics Network, Calgary, Alberta, Canada
Francesca Briganti (Graduate student), Department of Genome Biology, EMBL, Heidelberg, Baden-Wurttemberg, Germany
Pei-Yin Hsu (Postdoctoral Fellow), Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte, CA, USA
Shwetal Mehta (Assistant Professor), Laboratory of Glial Tumor Biology, Barrow Brain Tumor Research Center, Phoenix, AZ, USA
Nazanin Karimnia (Graduate Student), Department of Medicine, Nursing and Health science, Monash University, Prahran, Victoria, Australia
Pieter Van Vlierberghe (Associate Professor), Department of Paediatrics and Genetics, Ghent University, Ghent, Flanders, Belgium
Valentina Perrera (Postdoctoral Fellow), Department of Life Sciences, UNIMORE, Modena, Italy
Olga de la Caridad Torres (Postdoctoral Fellow), Cancer Epigenetic and Molecular Biology Program (PEBC), IDIBELL, Barcelona, Cataluña, Spain
Filipe Pereira (Assistant Professor), Department of UCBiotech, Center Of Neurosciences and Cell Biology, Cantanhede, Portugal
Maosumeh Es-haghi (Postdoctoral Fellow), Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran

Society Web Portal Contents:

Scientific meetings
Epigenetics modifiers
Epigenetics drugs
Advocacy & Support groups
Cancers & other neoplasms
Cancer epigenetics clinical trials
Cancer cell lines
Cancer epigenetics experiments